USA Clinical Next-Generation Sequencing Market Assessment 2020-2026

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Clinical Next-Generation Sequencing Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Targeted Sequencing Market Performance (Volume)
  • 2.1.2 Exome Sequencing Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.2.1 Targeted Sequencing Market Performance (Value)
  • 2.2.2 Exome Sequencing Market Performance (Value)

3 Market Assessment by Application

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Hospitals and Clinics Market Performance (Volume)
  • 3.1.2 Biopharma Companies Market Performance (Volume)
  • 3.1.3 Academic and Research Organizations Market Performance (Volume)
  • 3.1.4 Others Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Thermo Fisher Scientific
  • 4.1.1 Thermo Fisher Scientific Profiles
  • 4.1.2 Thermo Fisher Scientific Product Information
  • 4.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Business Performance
  • 4.1.4 Thermo Fisher Scientific Clinical Next-Generation Sequencing Business Development and Market Status
• 4.2 PerkinElmer
  • 4.2.1 PerkinElmer Profiles
  • 4.2.2 PerkinElmer Product Information
  • 4.2.3 PerkinElmer Clinical Next-Generation Sequencing Business Performance
  • 4.2.4 PerkinElmer Clinical Next-Generation Sequencing Business Development and Market Status
• 4.3 Illumina
  • 4.3.1 Illumina Profiles
  • 4.3.2 Illumina Product Information
  • 4.3.3 Illumina Clinical Next-Generation Sequencing Business Performance
  • 4.3.4 Illumina Clinical Next-Generation Sequencing Business Development and Market Status
• 4.4 Beckman Coulter
  • 4.4.1 Beckman Coulter Profiles
  • 4.4.2 Beckman Coulter Product Information
  • 4.4.3 Beckman Coulter Clinical Next-Generation Sequencing Business Performance
  • 4.4.4 Beckman Coulter Clinical Next-Generation Sequencing Business Development and Market Status
• 4.5 GATC Biotech
  • 4.5.1 GATC Biotech Profiles
  • 4.5.2 GATC Biotech Product Information
  • 4.5.3 GATC Biotech Clinical Next-Generation Sequencing Business Performance
  • 4.5.4 GATC Biotech Clinical Next-Generation Sequencing Business Development and Market Status
• 4.6 Qiagen
  • 4.6.1 Qiagen Profiles
  • 4.6.2 Qiagen Product Information
  • 4.6.3 Qiagen Clinical Next-Generation Sequencing Business Performance
  • 4.6.4 Qiagen Clinical Next-Generation Sequencing Business Development and Market Status
• 4.7 Roche
  • 4.7.1 Roche Profiles
  • 4.7.2 Roche Product Information
  • 4.7.3 Roche Clinical Next-Generation Sequencing Business Performance
  • 4.7.4 Roche Clinical Next-Generation Sequencing Business Development and Market Status
• 4.8 Pacific Bioscience
  • 4.8.1 Pacific Bioscience Profiles
  • 4.8.2 Pacific Bioscience Product Information
  • 4.8.3 Pacific Bioscience Clinical Next-Generation Sequencing Business Performance
  • 4.8.4 Pacific Bioscience Clinical Next-Generation Sequencing Business Development and Market Status
• 4.9 Agilent Technologies
  • 4.9.1 Agilent Technologies Profiles
  • 4.9.2 Agilent Technologies Product Information
  • 4.9.3 Agilent Technologies Clinical Next-Generation Sequencing Business Performance
  • 4.9.4 Agilent Technologies Clinical Next-Generation Sequencing Business Development and Market Status
• 4.10 Macrogen
  • 4.10.1 Macrogen Profiles
  • 4.10.2 Macrogen Product Information
  • 4.10.3 Macrogen Clinical Next-Generation Sequencing Business Performance
  • 4.10.4 Macrogen Clinical Next-Generation Sequencing Business Development and Market Status
• 4.11 Oxford Nanopore
• 4.12 Foundation Medicine
• 4.13 Life technologies
• 4.14 Exosome Diagnostics
• 4.15 CLC Bio
• 4.16 Paradigm
• 4.17 Partek
• 4.18 GnuBIO
• 4.19 Caris Life Sciences
• 4.20 Macrogen

5 Market Performance for Manufacturers

• 5.1 USA Clinical Next-Generation Sequencing Sales (K Units) and Market Share by Manufacturers (2014-2020)
• 5.2 USA Clinical Next-Generation Sequencing Revenue (M USD) and Market Share by Manufacturers (2014-2020)
• 5.3 USA Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
• 5.4 USA Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 Northeast Market Performance for Manufacturers
  • 6.1.1 Northeast Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers (2014-2020)
  • 6.1.2 Northeast Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers (2014-2020)
  • 6.1.3 Northeast Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
  • 6.1.4 Northeast Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
  • 6.1.5 Market Concentration
• 6.2 Midwest Market Performance for Manufacturers
  • 6.2.1 Midwest Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers (2014-2020)
  • 6.2.2 Midwest Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers (2014-2020)
  • 6.2.3 Midwest Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
  • 6.2.4 Midwest Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
  • 6.2.5 Market Concentration
• 6.3 South Market Performance for Manufacturers
  • 6.3.1 South Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers (2014-2020)
  • 6.3.2 South Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers (2014-2020)
  • 6.3.3 South Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
  • 6.3.4 South Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
  • 6.3.5 Market Concentration
• 6.4 West Market Performance for Manufacturers
  • 6.4.1 West Clinical Next-Generation Sequencing Sales (K Units) and Share of Manufacturers (2014-2020)
  • 6.4.2 West Clinical Next-Generation Sequencing Revenue (M USD) and Share of Manufacturers (2014-2020)
  • 6.4.3 West Clinical Next-Generation Sequencing Price (USD/Unit) of Manufacturers (2014-2020)
  • 6.4.4 West Clinical Next-Generation Sequencing Gross Margin of Manufacturers (2014-2020)
  • 6.4.5 Market Concentration

7 USA Clinical Next-Generation Sequencing Market Performance (Sales Point)

• 7.1 USA Clinical Next-Generation Sequencing Sales (K Units) and Market Share by Regions (2014-2020)
• 7.2 USA Clinical Next-Generation Sequencing Revenue (M USD) and Market Share by Regions (2014-2020)
• 7.3 USA Clinical Next-Generation Sequencing Price (USD/Unit) by Regions (2014-2020)
• 7.4 USA Clinical Next-Generation Sequencing Gross Margin by Regions (2014-2020)

8 Development Trend for Regions (Sales Point)

• 8.1 USA Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)
• 8.2 Northeast Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)
• 8.3 Midwest Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)
• 8.4 South Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)
• 8.5 West Clinical Next-Generation Sequencing Sales and Growth, Sales Value and Growth Rate(2014-2020)

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Hospitals and Clinics Industry
• 11.2 Biopharma Companies Industry
• 11.3 Academic and Research Organizations Industry

12 Market Forecast 2021-2026

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
  • 12.1.1 USA Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
  • 12.1.2 USA Clinical Next-Generation Sequencing Sales (K Units) and Growth Rate 2021-2026
  • 12.1.3 Northeast Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.4 Midwest Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.5 South Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.6 West Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.7 Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.8 Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.9 Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.1.10 Clinical Next-Generation Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
• 12.3 Sales (K Units), Revenue (M USD) by Types 2021-2026
  • 12.3.1 Overall Market Performance
  • 12.3.2 Targeted Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
  • 12.3.3 Exome Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
• 12.4 Sales by Application 2021-2026
  • 12.4.1 Overall Market Performance
  • 12.4.2 Hospitals and Clinics Sales and and Growth Rate 2021-2026
  • 12.4.3 Biopharma Companies Sales and and Growth Rate 2021-2026
  • 12.4.4 Academic and Research Organizations Sales and and Growth Rate 2021-2026
  • 12.4.5 Others Sales and and Growth Rate 2021-2026
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 USA Clinical Next-Generation Sequencing Price (USD/Unit) Trend 2021-2026
  • 12.5.2 USA Clinical Next-Generation Sequencing Gross Profit Trend 2021-2026

13 Conclusion